We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Dye May Diagnose Early Alzheimer's

By HospiMedica staff writers
Posted on 07 Sep 2005
Investigators have developed a new dye that may provide a noninvasive early diagnosis of Alzheimer's disease (AD), a finding that could also help in tracking the progression of the disease and in studying the effectiveness of new treatments to stop it.

Currently, clinicians can only make a definitive diagnosis of AD--currently the fourth-leading cause of death in the United States--through a postmortem autopsy of the brain. More...
"Before you can cure Alzheimer's, you have to be able to diagnose it and monitor its progress very precisely,” commented Dr. Timothy Swager, lead investigator of the study and a professor in the department of chemistry of the Massachusetts Institute of Technology (MIT, Cambridge, MA, USA).

To accomplish this task, Dr. Swager and worked with researchers at Massachusetts General Hospital (Boston, MA, USA) and the University of Pittsburgh (PA, USA) to develop a contrast agent that would first bind to the protein deposits, or plaques, in the brain that cause AD, and then fluoresce when exposed to radiation in the near-infrared range. The new dye could provide direct imaging of Alzheimer's plaques through a patient's skull.

Some of the first noninvasive methods for detecting AD involved agents labeled with radioactive elements that could enter the brain and target disease plaque for imaging with positron emission tomography (PET) imaging. However, these techniques were costly and limited by the short working lifetime of the labeled agents.

Dr. Swager and coworkers developed the new dye, called NIAD-4, through a targeted design process based on a set of certain requirements, including the ability to enter the brain rapidly upon injection, attach to amyloid plaques, absorb and fluoresce radiation in the right spectral range, and provide a clear contrast between the plaques and the surrounding tissue. The dye provided sharp visual images of amyloid brain plaques in living mice with specially prepared cranial windows.

To make the technique truly noninvasive, researchers must additionally refine the dye so it fluoresces at a slightly longer wavelength, closer to the infrared (IR) region. Light in the near-IR range can penetrate living tissue well enough to make brain structures visible.

The new dye was developed as part of a wider effort in sensing technology at MIT's Institute for Soldier Nanotechnologies. The study was published in the Aug. 26, 2005, issue of the journal Angewandte Chemie.


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Electrode Solution and Skin Prep
Signaspray
Digital X-Ray Detector Panel
Acuity G4
Spirometry & Oximetry Software
MIR Spiro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.